Related Experiment Video
Updated: Aug 9, 2026
06:03
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Peptide hormones and lung cancer
1Department of Health and Human Services, National Cancer Institute, Center for Cancer Research, Office of the Director, Bethesda, MD 20892, USA. moodyt@mail.nih.gov
Panminerva Medica
|April 25, 2006
Summary
Targeting peptide hormone receptors like gastrin-releasing peptide (GRP), neurotensin (NT), and adrenomedullin (AM) shows promise for inhibiting small cell lung cancer (SCLC) growth. These antagonists enhance chemotherapy effectiveness, offering new therapeutic strategies for lung cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Small cell lung cancer (SCLC) is a neuroendocrine cancer.
- SCLC cells produce autocrine growth factors: gastrin-releasing peptide (GRP), neurotensin (NT), and adrenomedullin (AM).
- These factors bind to G-protein coupled receptors, influencing cell proliferation and oncogene expression.
Purpose of the Study:
- To investigate the role of peptide hormones and their receptors in lung cancer proliferation.
- To evaluate the therapeutic potential of receptor antagonists in SCLC and non-small cell lung cancer (NSCLC).
- To explore new treatment strategies for lung cancer.
Main Methods:
- Investigated the effects of GRP, NT, and AM on SCLC cell growth and oncogene expression.
- Developed and tested antagonists for GRP, NT, and AM receptors as cytostatic agents.
- Examined the density of GRP, NT, AM, and epidermal growth factor (EGF) receptors in NSCLC cells.
- Assessed the efficacy of gefitinib, an EGF receptor tyrosine kinase inhibitor, in NSCLC patients.
Main Results:
- GRP, NT, and AM stimulate SCLC growth by altering oncogene expression.
- Receptor antagonists for GRP, NT, and AM inhibit SCLC growth and enhance chemotherapy efficacy.
- NSCLC cells express high levels of GRP, NT, AM, and EGF receptors.
- Gefitinib shows efficacy in NSCLC patients with EGF receptor mutations.
Conclusions:
- GRP, NT, and AM receptors are potential molecular targets for SCLC therapy.
- Receptor antagonists can serve as cytostatic agents and potentiate chemotherapy.
- Targeting growth factor receptors, like EGF receptors with gefitinib, offers therapeutic benefits for NSCLC.
- Translational research is crucial for developing novel lung cancer treatments.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:21Types of Hormones
Hormones are classified into four main groups: steroids, eicosanoids, amino acid-based derivatives, and peptide hormones.
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
02:13Types of Hormones
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
01:26Secondary Messengers in Hormone Action
Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
01:19Regulation of Hormone Secretion
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral stimuli,...
Humoral stimuli,...